×

Biotech and Pharmaceuticals Pharmaceuticals

  • Emergency room nurse Christine Bauer treats Joshua Lagade of Vista, California, for the flu as his girlfriend Mayra Mora looks on in the emergency room at Palomar Medical Center in Escondido, California, U.S., January 18, 2018.

    With a nasty flu season underway, businesses can expect to see billions of dollars in lost productivity, according to Andy Challenger.

  • Jan 19- Delaware on Friday became the latest state to file a lawsuit accusing corporations of helping fuel the national opioid epidemic, suing a wide range of companies involved in making, distributing and selling prescription painkillers. The lawsuit, filed by Delaware Attorney General Matt Denn in a state court, targeted drugmakers Purdue Pharma LP and Endo...

  • President Donald Trump attends a discussion on making changes to the prison system on Thursday January 11, 2018 in Washington, D.C.

    President Donald Trump has repeatedly condemned high drug prices but hasn't done much to lower them one year in office.

  • The plan puts the FDA at the center of a long-standing debate over so-called "reduced-risk" products, such as e-cigarettes, and whether they should have a role in anti-smoking efforts, which have long focused exclusively on getting smokers to quit. The FDA plan is two-fold: drastically cut nicotine levels in cigarettes so that they are essentially...

  • LONDON, Jan 19- A focus on fewer diseases, together with cuts in laboratories and staff, has delivered a more than fourfold increase in research productivity at drugmaker AstraZeneca, based on one key measure of success. "All these improvements have happened with less people, less sites and less money," Mene Pangalos, who leads AstraZeneca's Innovative Medicines...

  • Dr. Marc Harrison, Intermountain Health CEO.

    A consortium representing more than 450 hospitals plan to create their own generic drug company.

  • Dr. Marc Harrison, Intermountain Health CEO.

    Dr. Marc Harrison, Intermountain Healthcare president & CEO, discusses his hospital's plan to manufacture its own drugs as a means to combat rising drug costs.

  • TRENTON, N.J.— Several major not-for-profit hospital groups are trying their own solution to drug shortages and high prices: creating a company to make cheaper generic drugs. The not-for-profit drug company initially will be backed by four hospital groups— Intermountain Health, Ascension and two Catholic health systems, Trinity Health and SSM Health— plus the...

  • NEW YORK, Jan 18- A group of four hospital systems plans to launch a not-for-profit generic drugmaker aimed at combating shortages and high costs of some generic drugs, which they blame on unscrupulous drug companies that hike prices. Intermountain Healthcare said on Thursday it was working with three other large U.S.-based hospital systems including...

  • MONTPELIER, Vt.— The Vermont Senate is considering a proposal to save money on prescription drugs by importing them from Canada, where many are sold for a fraction of the cost in the United States. He supports the proposal that was discussed Thursday during a meeting of the Senate Health and Welfare Committee. The Pharmaceutical Research and Manufacturers of...

  • Retail prescriptions set to reach $4 billion this year.

    Several major hospital systems plan to form a drug company that will provide generic drugs in short supply to the hospitals, the New York Times reports.

  • NEW YORK, Jan 18- A U.S. administrative court invalidated a Johnson& Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and hitting shares in its British partner BTG Plc.. Wednesday's ruling was a victory for U.S. generic drug company Argentum Pharmaceuticals LLC, which had asked the board to...

  • TOKYO, Jan 18- Japan's Nikkei share average soared to a level not seen since November 1991 on Thursday morning after exporters such as electronics components manufacturers surged, tracking the strength on Wall Street overnight. The Nikkei rose 0.4 percent to 23,962.11 in midmorning trade, after hitting 24,084.42, the highest level since November 1991.

  • NEW YORK, Jan 17- A U.S. administrative court on Wednesday invalidated a Johnson& Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions. The ruling was a victory for U.S. generic drug company Argentum Pharmaceuticals LLC, which had asked the board to invalidate the patent in hopes of bringing its own...

  • Juno Therapeutics Inc., up $23.65 to $69.25. The Wall Street Journal reported that biotech drugmaker Celgene may buy the cancer therapy company. Ford Motor Co., down 92 cents to $12.18.

  • PHILADELPHIA— Philadelphia has filed a lawsuit against drug companies that make prescription opioids, saying they've created "an unprecedented public health crisis." It seeks to halt what the city calls "deceptive marketing practices" and force the drug makers to pay for treatment costs and reimburse the city for the money it has spent responding to the...

  • LONDON, Jan 17- GlaxoSmithKline is cutting back operations in Africa as its new Chief Executive Emma Walmsley seeks to make the British drugmaker more competitive in emerging markets by ditching her predecessor's expansion plans for the continent. Today, the same experts at research company IQVIA, previously known as IMS Health, suggest it is more likely to be...

  • ZURICH, Jan 17- Swiss secrecy could be rolled back further under a plan to eliminate a class of company share that can be used to help owners dodge taxes by hiding their identities. Long seen as a haven for the wealthy to stash their money, Switzerland has already dismantled banking secrecy by agreeing to send information about customers' accounts to foreign tax...

  • ZURICH, Jan 17- Swiss secrecy could be rolled back further under a plan to eliminate a class of company share that can be used to help owners dodge taxes by hiding their identities. Long seen as a haven for the wealthy to stash their money, Switzerland has already dismantled banking secrecy by agreeing to send information about customers' accounts to foreign tax...

  • Winners & losers from JP Morgan Healthcare Conference

    Jim Cramer listed the J.P. Morgan's Healthcare Conference's best and worst performers judging by the stock market's reaction.